Newsroom

LONDON--(BUSINESS WIRE)--  Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser SAMSON ROCK CAPITAL LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trus...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

BOCA RATON, Fla.--(BUSINESS WIRE)--Bellacor today announced the launch of its completely redesigned website, marking a significant evolution for the premium home furnishings and lighting retailer. The new Bellacor.com experience introduces a refined digital destination where design professionals and consumers can discover thoughtfully curated products, inspiring content and elevated design solutions tailored to today's luxury lifestyles. Designed to inspire from the first click, the reimagined...

中国深圳--(BUSINESS WIRE)--(美国商业资讯)-- 深圳微芯生物科技股份有限公司（简称“微芯生物”，股票代码：688321.SH）宣布，公司依托AI+化学基因组学的整合式核心技术平台自主研发的新一代透脑Aurora B选择性抑制剂CS231295，在美国开展的I期临床试验已于近日完成首例患者给药。 本研究是一项针对晚期实体瘤的开放标签、剂量递增I期临床试验，旨在评估CS231295在晚期实体瘤患者中的安全性、耐受性、药代动力学特征及初步抗肿瘤活性。 微芯生物创始人、董事长鲁先平博士表示：“CS231295在美国的首例患者已顺利完成首次给药，感谢参与试验的患者和研究中心的支持。CS231295全球临床开发从一开始就采取‘中美双报双批’策略，致力于攻克RB1缺失与脑转移这两类最难治的实体瘤，在美国这一全球新药开发的核心市场启动临床，对团队意义深远。首例给药是起点，我们将秉持科学精神，稳步推进后续研究，以严谨扎实的临床数据，对患者负责、对科学负责。” 恶性脑部肿瘤及肿瘤脑转移是肿瘤治疗领域长期面临的重大挑战，开发具备脑透过性的新型抗肿瘤药物已成为亟需解决的临床难题。基于在相关...

NEW YORK--(BUSINESS WIRE)--MarketAxess Holdings Inc. (Nasdaq: MKTX) the operator of a leading electronic trading platform for fixed-income securities, will issue a press release announcing its second quarter 2026 financial results on Friday, August 7, 2026, before the market opens. Chris Concannon, Chief Executive Officer, and Ilene Fiszel Bieler, Chief Financial Officer, will host a conference call to provide a strategic update and discuss the Company’s financial results and outlook on Friday,...

DUBLIN--(BUSINESS WIRE)--Smurfit Westrock plc (NYSE:SW) plans to release its financial results for the second quarter ended June 30, 2026 on Wednesday, July 29, 2026 at 6.30 am ET (11.30 am BST). Smurfit Westrock’s earnings release and related materials will be available at smurfitwestrock.com. At 7.30 am ET (12.30 pm BST) on the same day, Smurfit Westrock’s senior management team will host a webcast for analysts and institutional investors. The webcast will be available at https://investors.sm...

COLUMBUS, Ohio--(BUSINESS WIRE)--Worthington Steel announced the start of the acceptance period for its Public Delisting Tender Offer for outstanding Kloeckner & Co SE shares....

TULSA, Okla.--(BUSINESS WIRE)--NGL Energy Partners Announces Earnings Call...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Large Cap Core AlphaDEX UCITS ETF 14.07.2026 FEXD.LN IE00BWTNMB87  451,437.00 USD  45,370,028.81  100.501  ...